Cohance Lifesciences Limited (COHANCE) Share Price & AI Investment Analysis

Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms (FDE). Track Cohance Lifesciences Limited's live NSE:COHANCE share price ₹452.75 (-1.36%), market cap ₹₹173B, P/E 164.0. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for COHANCE — real-time NSE India stock intelligence.